Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Paz (5)

2019

  1. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment

    World Journal of Gastroenterology, Vol. 25, Núm. 38, pp. 5883-5896

2018

  1. According to hepatitis C virus (HCV) infection stage, interleukin-7 plus 4-1BB triggering alone or combined with PD-1 blockade increases TRAF1low HCV-specific CD8+ cell reactivity

    Journal of Virology, Vol. 92, Núm. 2

2015

  1. Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

    Liver International, Vol. 35, Núm. 1, pp. 90-100

  2. Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

    Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480

2006

  1. Mast cell quantification in normal peritoneum and during peritoneal dialysis treatment

    Archives of Pathology and Laboratory Medicine, Vol. 130, Núm. 8, pp. 1188-1192